Search | IOVS | ARVO Journals

View

Showing 1 – 11 of 11

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Intravitreal administration of AAV2-SIRT1 reverses diabetic retinopathy (DR) in a murine model of type 2 diabetes (T2D)

Maria B Grant; Yvonne Adu-Agyeiwaah; Cristiano P. Vieira; Bright Asare-Bediako; Sandra S Hammer; Sergio Li Calzi; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2310. doi:

ARVO Annual Meeting Abstract June 2022

Maintenance of intestinal ACE2 minimizes the risk of developing diabetic retinopathy in type 1 diabetes

Ram Prasad; Jason Floyd; Bright Asare-Bediako; Dibyendu Chakraborty; Yvonne Adu-Agyeiwaah; Angela Harbour; Qiuhong Li; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2309. doi:

ARVO Annual Meeting Abstract June 2022

DIFFERENTIAL RECUITMENT OF HEMATOPOIETIC CELLS INTO THE INJURED RPE/CHOROID

Bright Asare-Bediako; Sergio Li Calzi; Yvonne Adu-Agyeiwaah; Jason Floyd; Mariana D DuPont; Maria Grant

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3025 – F0396. doi:

ARVO Annual Meeting Abstract June 2022

Oral administration of alpha-cyclodextrin reverses diabetic retinopathy in db/db mice

Yvonne Adu-Agyeiwaah; Sandra S Hammer; Cristiano P. Vieira; Bright Asare-Bediako; Jason Floyd; Mariana D DuPont; Ram Prasad; Sergio Li Calzi; Julia V Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3591 – A0046. doi:

ARVO Annual Meeting Abstract June 2021

Physiological Recruitment of Hematopoietic Cells and Innervation in the Developing Retina

Bright Asare-Bediako; Chao Huang; Cristiano P. Vieira; Yvonne Adu-Agyeiwaah; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1698. doi:

ARVO Annual Meeting Abstract June 2021

Intravitreal AAV2-SIRT1 administration reverses diabetic retinopathy in db/db mice

Yvonne Adu-Agyeiwaah; Cristiano P. Vieira; Bright Asare-Bediako; Sandra S Hammer; Sergio Li Calzi; Julia V Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1106. doi:

ARVO Annual Meeting Abstract June 2020

Oral administration of engineered probiotic prevents gut dysbiosis in type 1 diabetes and alleviates diabetic retinopathy (DR)

Ram Prasad; Jason L. Floyd; DIBYENDU CHAKRABORTY; Bright Asare-Bediako; Yvonne Adu-Agyeiwaah; Sergio Li Calzi; Robert F. Rosencrans; Chao Huang; Mariana DuPont; Sunil K Noothi; Qiuhong Li; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1169. doi:

ARVO Annual Meeting Abstract June 2020

LXR activation prevents development of diabetic retinopathy (DR) in db/db mice by controlling cholesterol and stem cell profiles

Yvonne Adu-Agyeiwaah; Cristiano P Vieira; Ana Leda Longhini; Bright Asare-Bediako; Micheli Sielski; Mariana DuPont; Sergio Li Calzi; Julia Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5161. doi:

ARVO Annual Meeting Abstract July 2019

In Vivo Retinal Structural Lesions, Functional Deficits and Peripheral Blood Cell phenotype in Mice with High-Fat Diet-Induced Retinopathy

Bright Asare-Bediako; Sunil Nooti; Sergio Li Calzi; Baskaran Athmanathan; Cristiano Pedrozo Vieira; Ana Leda Figueiredo Longhini; Mariana Dupont; DIBYENDU CHAKRABORTY; Prabhakara R Nagareddy; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2688. doi:

ARVO Annual Meeting Abstract July 2019

Targeting LXR using N,N-dimethyl-3ß-hydroxycholenamide (DMHCA) provides protection from development of diabetic retinopathy in db/db mice

Cristiano Pedrozo Vieira; Ana Leda Figueiredo Longhini; Sergio L Calzi; Bright Asare-Bediako; Mariana Dupont; Julia V Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2788. doi:

ARVO Annual Meeting Abstract July 2019

A PLGA-Carboxyamidotriazole (CAI) Polymeric Suspension Suppresses Pathological Ocular Angiogenesis in rodent CNV model.

Sergio Li Calzi; DIBYENDU CHAKRABORTY; Bright Asare-Bediako; Isabel Franklin; Srikanth Kakumanu; Laurent Balenci; Maria B Grant; Alan Franklin

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5411. doi:

Advertisement